Skip to main content

Zocaglusagene Nuzaparvovec

Chemical FDA Substance Registry (openFDA)
Chemical Identification
CAS Number2601264-52-0
Known Aliases (6)
Common Name
AT-845 AT845 DNA (recombinant adeno-associated virus vector AT845 mouse muscle-type creatine kinase enhancer plus mouse muscle-type creatine kinase promoter plus human lysosomal α-glucosidase precursor codon-optimized transgene plus simian virus 40 polyadenylation signal plus adeno-associated virus 2 inverted terminal repeat flanks-specifying) Recombinant, non-replicating adeno-associated virus serotype 8 (rAAV8) vector encoding codon-optimized human acid alpha-glucosidase (GAA), also called lysosomal α-glucosidase or acid maltase, under control of a mouse muscle creatine kinase (MCK) enhancer/promoter followed by a simian virus 40 (SV40) intron, terminated by the SV40 late polyadenylation sequence, and flanked by AAV2 inverted terminal repeats (ITRs) zocaglusagene nuzaparvovec [INN] ZOCAGLUSAGENE NUZAPARVOVEC [USAN]
Data Sources (1)
Source Source ID Name in Source Properties
FDA Substance Registry (openFDA) FDB4GQ8A3Y Zocaglusagene Nuzaparvovec CAS: 2601264-52-0
INN: 12248
USAN: LM-146
SMS_ID: 300000044947
FDA UNII: FDB4GQ8A3Y
NCI_THESAURUS: C190444
Record Info
IDMCXPyv7fn88uVNBX4e8RvS
CreatedApril 10, 2026, 8:13 p.m.
ModifiedApril 11, 2026, 12:27 a.m.
Data SourceFDA Substance Registry (openFDA)